IGY Immune Technologies & Life Sciences Inc.
ActiveFederal corporation under the Canada Business Corporations Act
IGY Immune Technologies & Life Sciences Inc. is an active federal corporation (corporation number 7199384). Its business number is 854065661. It was incorporated on Jun 30, 2009 under the Canada Business Corporations Act and its registered office is in Airdrie, Alberta. Its annual returns are up to date, most recently for 2026. It has one director on record.
Corporation
- Corporation number
- 7199384
- Business number
- 854065661
- Status
- Active
- Governing law
- Canada Business Corporations Act
- Incorporated
- Jun 30, 2009
- Number of directors
- At least 1, at most 10
- Corporation type
- Non-distributing corporation with more than 50 shareholders
- Registered office
- 4 East Lake Ave NE
Unit 1A
Airdrie AB T4A 2G8
Annual filings
- Anniversary date
- Jun 30
- Annual filing period
- Jun 30 to Aug 29
- Last annual meeting
- Apr 17, 2026
- Last annual return filed
- 2026
| Year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Annual return | Filed | Filed | Filed |
The last annual return filed, and each year since.
Directors (1)
| Name | Address for service |
|---|---|
| Brad Trumble | 2211 Lake Bonavista Drive Southeast Calgary AB T2J 2Z9 |
As listed on the federal record on Oct 30, 2026. A director may give an address for service instead of a home address.
Names, filings and certificates
| Name | Form | In use since |
|---|---|---|
| IGY Immune Technologies & Life Sciences Inc. | Name | Jun 30, 2009 |
| What | Date |
|---|---|
| Articles amended | Mar 21, 2025 |
| Incorporated | Jun 30, 2009 |
About this report
Prepared by Canada Corporation Registry on Nov 17, 2026 from the federal corporations data as it stood that day and the corporation's federal record as last read. It is not an official record or a certificate of compliance. Check the federal record before relying on it: ised-isde.canada.ca/cc/lgcy/fdrlCrpDtls.html?corpId=7199384
Contains information licensed under the Open Government Licence – Canada.